Skip to main content

Table 5 Accuracy of the gene-neutral two-stage and single classifiers.

From: Identifying the status of genetic lesions in cancer clinical trial documents using machine learning

Testing Gene Training Genes Two-stage Classifier Single-stage Classifier
ALK BRAF, EGFR, KIT, KRAS, MET, PTEN, WT1 68.6% 64.7%
BRAF ALK, EGFR, KIT, KRAS, MET, PTEN, WT1 85.4% 84.6%
EGFR ALK, BRAF, KIT, KRAS, MET, PTEN, WT1 78.0% 73.5%
KIT ALK, BRAF, EGFR, KRAS, MET, PTEN, WT1 74.5% 70.3%
KRAS ALK, BRAF, EGFR, KIT, MET, PTEN, WT1 87.0% 81.5%
MET ALK, BRAF, EGFR, KIT, KRAS, PTEN, WT1 73.5% 41.5%
PTEN ALK, BRAF, EGFR, KIT, KRAS, MET, WT1 78.3% 78.3%
WT1 ALK, BRAF, EGFR, KIT, KRAS, MET, PTEN 65.0% 55.7%
Average   76.3% 68.8%